{ }
001122334455554433221100
001122334455554433221100

ubs raises treace medical concepts price target to ten dollars maintains neutral rating

UBS has raised the price target for Treace Medical Concepts, Inc. to $10 from $7.90 while maintaining a neutral rating. The company specializes in medical technology for bunion and midfoot deformities, offering patented systems like the Lapiplasty 3D Bunion Correction System and the Adductoplasty Midfoot Correction System, which are designed to improve surgical outcomes and patient recovery. Their products are sold to healthcare providers across the United States.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.